化学合成。
医药
合成路线 1(1. 合成:2436-29-5)
产率:94%
合成条件:With N-benzyl-trimethylammonium hydroxide In methanol; ethyl acetate at 65 - 70℃; for 1 h;
实验步骤:向5L反应烧瓶中加入1.5L乙酸乙酯,原料邻苯二甲酰亚胺(441.4g,3.0mol,1.0eq),机械搅拌,然后加入丙烯醛进料(240.6mL,3.6mol,1.2eq),30分钟内制得。 加热至65℃,向MeOH中加入40wt%BnNMe 3 OH(2.0mL,0.0015当量),反应体系在65-70℃下25分钟,然后在MeOH中加入40wt%BnNMe 3 OH(2.0mL,0.0015当量),接着 通过65-70℃反应35分钟,TLC(1:1乙酸乙酯/己烷)显示没有原料B2.1L在加热的同时加入己烷,然后加入少许冷的正己烷2L在室温下搅拌过夜,过滤得到白色 用MTBE(3×600mL)洗涤并干燥得到固体,得到573.8g 3- [2-(1,3-二异吲哚啉-1)]丙醛,产率:94%。
参考文献:
- [1] Angewandte Chemie - International Edition, 2017, vol. 56, # 25, p. 7218 - 7222 [2] Angew. Chem., 2017, vol. 129, # 25, p. 7324 - 7328,5 [3] Patent: CN105906569, 2016, A. Location in patent: Paragraph 0050; 0051 [4] Phytochemistry (Elsevier), 1986, vol. 25, # 12, p. 2753 - 2758 [5] Journal of the Chemical Society, 1952, p. 2448 [6] Journal of Organic Chemistry, 2015, vol. 80, # 20, p. 9847 - 9855
合成路线 2(2. 合成:2436-29-5)
产率:100%
合成条件:With 2-iodoxybenzoic acid In ethyl acetate for 2 h; Reflux
实验步骤:步骤2.制备3-(1,3-二氧代异吲哚啉-2-基)丙醛2-(3-羟丙基)异吲哚啉-1,3-二酮(2.0g,8.76mmol)和IBX的混合物(8.2g,29.27) 将在60mL EA中的mmol)回流2小时。 过滤混合物,浓缩滤液,得到3-(1,3-二氧代异吲哚啉-2-基)丙醛(2.0g,收率:100%),为白色固体。 NMR(500MHz,CDCl 3):δ9.82(s,2H),7.84-7.86(m,2H),7.72-7.74(m,2H),4.04(t,J = 7.0Hz,2H),2.87-2.89( m,2H)ppm。 MS(ESI):m / z 553.7 [M + 1] +。
参考文献:
- [1] Patent: WO2012/82436, 2012, A2. Location in patent: Page/Page column 245-246 [2] Organic and Biomolecular Chemistry, 2014, vol. 12, # 32, p. 6094 - 6104 [3] Journal of the American Chemical Society, 2006, vol. 128, # 12, p. 4023 - 4034 [4] Tetrahedron, 2002, vol. 58, # 9, p. 1719 - 1737 [5] Helvetica Chimica Acta, 2005, vol. 88, # 10, p. 2610 - 2616 [6] Journal of Organic Chemistry, 1989, vol. 54, # 22, p. 5387 - 5390 [7] Organic Letters, 2003, vol. 5, # 17, p. 3115 - 3118 [8] Green Chemistry, 2012, vol. 14, # 5, p. 1493 - 1501 [9] Journal of the American Chemical Society, 2013, vol. 135, # 24, p. 9083 - 9090 [10] Tetrahedron, 2003, vol. 59, # 45, p. 8877 - 8888 [11] Journal of Medicinal Chemistry, 1999, vol. 42, # 4, p. 706 - 721 [12] Bioorganic and Medicinal Chemistry, 2001, vol. 9, # 10, p. 2609 - 2624 [13] Journal of Organic Chemistry, 2017, vol. 82, # 24, p. 13121 - 13140 [14] Beilstein Journal of Organic Chemistry, 2017, vol. 13, p. 644 - 647 [15] Journal of the American Chemical Society, 1988, vol. 110, p. 5779 [16] Tetrahedron Letters, 1993, vol. 34, # 24, p. 3919 - 3920 [17] Journal of Medicinal Chemistry, 2004, vol. 47, # 10, p. 2411 - 2413 [18] Patent: US2006/84687, 2006, A1. Location in patent: Page/Page column 22 [19] Patent: US2005/119332, 2005, A1 [20] Organic Letters, 2009, vol. 11, # 11, p. 2465 - 2468 [21] Patent: WO2012/82436, 2012, A2. Location in patent: Page/Page column 223-224 [22] Patent: WO2012/82436, 2012, A2. Location in patent: Page/Page column 265-266 [23] Chemistry - A European Journal, 2013, vol. 19, # 20, p. 6213 - 6216
合成路线 3(3. 合成:2436-29-5)
产率:91.4%
合成条件:With hydrogenchloride; water; acetic acid In tetrahydrofuran at 20 - 50℃; for 2 h;
实验步骤:在四氢呋喃(12ml)和乙酸(4ml)的混合溶剂中溶解2- [2-(1,3-二氧戊环-2-基)乙基] -1H-异吲哚-1,3(2H) - 二酮 (728mg,2.94mmol),然后在室温下向其中加入2M盐酸水溶液(5ml),并将所得混合物在50℃下搅拌2小时。 反应完成后,将反应溶液用乙酸乙酯萃取。 依次用水,饱和碳酸氢钠水溶液和饱和氯化钠水溶液洗涤有机层,然后用无水硫酸钠干燥。 减压蒸馏除去溶剂,用己烷 - 乙醚混合溶剂洗涤得到的固体,得到标题化合物(546mg,91.4%)。 1H-NMR(DMSO-d6)9.65(br,1H),7.80-7.88(m,4H),3.84(t,2H,J = 4.4Hz),2.79(dt,2H,J = 1.5,6.9Hz)。
参考文献:
- [1] Patent: EP1640369, 2006, A1. Location in patent: Page/Page column 29 [2] Patent: WO2007/55513, 2007, A1. Location in patent: Page/Page column 23